News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,676 Results
Type
Article (38453)
Company Profile (118)
Press Release (607096)
Multimedia
Podcasts (72)
Webinars (11)
Section
Business (173265)
Career Advice (2771)
Deals (32517)
Drug Delivery (101)
Drug Development (73396)
Employer Resources (159)
FDA (15850)
Job Trends (14628)
News (301948)
Policy (29262)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2683)
Academic (1)
Accelerated approval (30)
Adcomms (28)
Allergies (144)
Alliances (43439)
ALS (174)
Alzheimer's disease (1702)
Antibody-drug conjugate (ADC) (294)
Approvals (16147)
Artificial intelligence (515)
Autoimmune disease (153)
Automation (35)
Bankruptcy (290)
Best Places to Work (12096)
BIOSECURE Act (18)
Biosimilars (182)
Biotechnology (82)
Bladder cancer (158)
Brain cancer (57)
Breast cancer (640)
Cancer (4782)
Cardiovascular disease (394)
Career advice (2318)
Career pathing (38)
CAR-T (282)
CDC (40)
Celiac Disease (2)
Cell therapy (755)
Cervical cancer (35)
Clinical research (63356)
Collaboration (1721)
Company closure (3)
Compensation (1157)
Complete response letters (53)
COVID-19 (2587)
CRISPR (92)
C-suite (857)
Cystic fibrosis (151)
Data (6291)
Decentralized trials (1)
Denatured (16)
Depression (131)
Diabetes (486)
Diagnostics (6928)
Digital health (44)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (243)
Drug pricing (161)
Drug shortages (21)
Duchenne muscular dystrophy (214)
Earnings (72035)
Editorial (58)
Employer branding (21)
Employer resources (143)
Events (107716)
Executive appointments (1012)
FDA (18999)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (9)
Frontotemporal dementia (24)
Funding (1468)
Gene editing (199)
Generative AI (40)
Gene therapy (587)
GLP-1 (855)
Government (4275)
Grass and pollen (7)
Guidances (381)
Healthcare (19901)
HIV (55)
Huntington's disease (43)
IgA nephropathy (80)
Immunology and inflammation (232)
Immuno-oncology (51)
Indications (104)
Infectious disease (2845)
Inflammatory bowel disease (193)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (250)
Interviews (546)
IPO (16337)
IRA (39)
Job creations (2889)
Job search strategy (1898)
JPM (53)
Kidney cancer (17)
Labor market (67)
Layoffs (504)
Leadership (37)
Legal (6417)
Liver cancer (84)
Longevity (14)
Lung cancer (628)
Lymphoma (367)
Machine learning (43)
Management (60)
Manufacturing (758)
MASH (164)
Medical device (14401)
Medtech (14457)
Mergers & acquisitions (17347)
Metabolic disorders (1169)
Multiple sclerosis (154)
NASH (14)
Neurodegenerative disease (320)
Neuropsychiatric disorders (85)
Neuroscience (2938)
Neurotech (1)
NextGen: Class of 2026 (6733)
Non-profit (4863)
Now hiring (53)
Obesity (504)
Opinion (283)
Ovarian cancer (166)
Pain (210)
Pancreatic cancer (224)
Parkinson's disease (295)
Partnered (32)
Patents (488)
Patient recruitment (489)
Peanut (58)
People (53332)
Pharmaceutical (30)
Pharmacy benefit managers (27)
Phase 1 (19784)
Phase 2 (28108)
Phase 3 (20934)
Pipeline (5136)
Policy (252)
Postmarket research (2027)
Preclinical (8061)
Press Release (62)
Prostate cancer (236)
Psychedelics (46)
Radiopharmaceuticals (287)
Rare diseases (845)
Real estate (4954)
Recruiting (67)
Regulatory (22875)
Reports (31)
Research institute (2509)
Resumes & cover letters (451)
Rett syndrome (27)
RNA editing (15)
RSV (76)
Schizophrenia (148)
Series A (236)
Series B (187)
Service/supplier (6)
Sickle cell disease (103)
Special edition (17)
Spinal muscular atrophy (156)
Sponsored (34)
Startups (3086)
State (2)
Stomach cancer (9)
Supply chain (98)
Tariffs (73)
The Weekly (55)
Vaccines (920)
Venture capital (80)
Weight loss (308)
Women's health (75)
Worklife (20)
Date
Today (22)
Last 7 days (618)
Last 30 days (2022)
Last 365 days (30795)
2026 (2938)
2025 (31231)
2024 (35979)
2023 (41330)
2022 (52215)
2021 (57120)
2020 (55635)
2019 (48790)
2018 (36672)
2017 (32208)
2016 (30506)
2015 (35621)
2014 (24895)
2013 (19399)
2012 (20880)
2011 (21661)
2010 (18742)
Location
Africa (781)
Alabama (89)
Alaska (7)
Arizona (232)
Arkansas (12)
Asia (37736)
Australia (6696)
California (11365)
Canada (3288)
China (1113)
Colorado (480)
Connecticut (488)
Delaware (336)
Europe (87855)
Florida (1688)
Georgia (371)
Hawaii (3)
Idaho (61)
Illinois (878)
India (62)
Indiana (527)
Iowa (21)
Japan (421)
Kansas (124)
Kentucky (41)
Louisiana (26)
Maine (83)
Maryland (1379)
Massachusetts (8344)
Michigan (342)
Minnesota (639)
Mississippi (5)
Missouri (135)
Montana (34)
Nebraska (27)
Nevada (126)
New Hampshire (84)
New Jersey (3059)
New Mexico (31)
New York (3007)
North Carolina (1519)
North Dakota (10)
Northern California (5552)
Ohio (342)
Oklahoma (22)
Oregon (42)
Pennsylvania (2289)
Puerto Rico (22)
Rhode Island (46)
South America (1095)
South Carolina (66)
South Dakota (1)
Southern California (4461)
Tennessee (173)
Texas (1770)
United States (40685)
Utah (349)
Vermont (1)
Virginia (271)
Washington D.C. (77)
Washington State (946)
West Virginia (3)
Wisconsin (119)
Wyoming (2)
645,676 Results for "swedish orphan ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ) - November 30, 2023
Swedish Orphan Biovitrum AB has, as previously announced, carried out a share issue of series C shares, which has resulted in changes in the number of shares and votes in Sobi.
November 30, 2023
·
1 min read
Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ) - September 29, 2023
Swedish Orphan Biovitrum AB has, as previously announced, carried out a rights issue of common shares, which has resulted in changes in the number of shares and votes in Sobi.
September 29, 2023
·
1 min read
Press Releases
The Caris Precision Oncology Alliance Welcomes Providence Swedish Cancer Institute
December 22, 2025
·
8 min read
Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)
The shareholders in Swedish Orphan Biovitrum AB Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting, to be held on Tuesday, 15 August 2023 at 10.00 at the offices of Mannheimer Swartling Advokatbyrå, Norrlandsgatan 21, Stockholm, Sweden.
July 18, 2023
·
12 min read
Deals
New number of shares and votes in Swedish Orphan Biovitrum AB (publ) - June 30, 2023
As per 30 June 2023 , the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 311,336,796 shares.
June 30, 2023
·
1 min read
Drug pricing
CMS Finalizes Stronger Protections for Orphan Drugs Against IRA Price Negotiations
Expanded exemptions for orphan drugs could mean prolonged protections for top-selling drugs like Merck’s Keytruda, which was initially approved under this designation in 2014.
October 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
January 8, 2026
·
11 min read
Press Releases
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
April 23, 2025
·
7 min read
Press Releases
Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma
February 5, 2026
·
10 min read
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
1 of 64,568
Next
